Genetically engineered models (GEMs) refer to any organisms, typically animals, whose genetic makeup has been intentionally altered using genetic engineering techniques. Alfa Cytology provides our clients with customized GEMs for bladder cancer research.
GEMs are created by introducing specific genetic modifications into the organism's genome. This can involve gene knockouts (deletion or inactivation of a specific gene), gene insertions (introduction of a new gene), gene mutations (alterations in the DNA sequence of a gene), or modifications in gene expression. GEMs can include not only mice (genetically engineered mouse models or GEMMs) but also other species such as rats, zebrafish, flies, and pigs, among others.
Fig.1 Potential genetic modifications in swine to develop bladder cancer models through CRISPR/Cas9 technology. (Zeng Y., et al. 2023)
GEMM and patient-derived xenograft (PDX) models are the most common in vivo models used in cancer research. These two approaches are considered complementary and can be used for different aspects of the disease. GEMM are usually induced by CRISPR-Cas9 and embryonic stem cell homologous recombination techniques. Their advantages are as follows:
CRISPR-Cas9 Gene-Editing Technology | ESC Homologous Recombination Technology |
---|---|
|
|
Alfa Cytology, a renowned preclinical contract research organization (CRO), is at the forefront of advancing bladder cancer research through its comprehensive range of customization services for genetically engineered models. We provide our clients with genetically engineered models of different animals, such as mice, rats, pigs, and dogs, among others.
We provide animal models of bladder cancer induced by CRISPR-Cas9 and embryonic stem cell homologous recombination technology.
At Alfa Cytology, we offer comprehensive and cutting-edge services for the development of genetically engineered models (GEMs) specifically tailored for bladder cancer research. Our team of experienced scientists and researchers utilizes advanced genetic engineering techniques to create precise and reliable models that mimic the genetic alterations observed in human bladder cancer. If you have any needs, please contact us.
Reference
Alfa Cytology is dedicated to drug development and preclinical services for bladder cancer.